Australia - inglese - Department of Health (Therapeutic Goods Administration)

orion laboratories pty ltd t/a perrigo australia - diazepam, quantity: 1 mg/ml - oral liquid, solution - excipient ingredients: ethanol; propylene glycol; glycerol; citric acid; sodium citrate dihydrate; purified water; flavour - indications as at 30 september 2003: diazepam is indicated in the management of anxiety disorders and for the short term relief of the symptoms of anxiety. diazepam is a useful adjunct for the relief of reflux muscle spasm due to local trauma (injury, inflammation) to muscles, bones and joints. it is also indicated in the management of cerebral spasiticity due to upper motor neuron lesions such as cerebral palsy and paraplegia, and spasticity in athetosis and stiff man syndrome. in acute alcohol withdrawal, diazepam may be useful in the symptomatic relief of acute agitation, tremor, impending or acute delirium tremens and hallucinosis.

Regno Unito - inglese - MHRA (Medicines & Healthcare Products Regulatory Agency)

am distributions (yorkshire) ltd - liquid paraffin light - bath additive - 634mg/1ml

Regno Unito - inglese - MHRA (Medicines & Healthcare Products Regulatory Agency)

j m mcgill ltd - liquid paraffin light - bath additive - 634mg/1ml

Stati Uniti - inglese - NLM (National Library of Medicine)

jubilant hollisterstier llc - liquidambar styraciflua pollen (unii: 5q246ds5bs) (liquidambar styraciflua pollen - unii:5q246ds5bs) - liquidambar styraciflua pollen 0.05 g in 1 ml - allergenic extracts are indicated for use in diagnosis and immunotherapy of patients presenting symptoms of allergy (hay fever, rhinitis, etc.) to specific environmental allergens. the selection of allergenic extracts to be used should be based on a thorough and carefully taken history of hypersensitivity, and confirmed by skin testing. the use of mixed or unrelated antigens for skin testing is not recommended since, in the case of a positive reaction, it does not indicate which component of the mix is responsible for the reaction, while, in the case of a negative reaction, it fails to indicate whether the individual antigens at full concentration would give a positive reaction. utilization of such mixes for compounding a treatment may result, in the former case, in administering unnecessary antigens and, in the latter case, in the omission of a needed antigen. avoidance of allergens is to be advocated if possible, but cannot always be attained, e.g., allergy to dog dander in kennel owners and employees,

Bangladesh - inglese - DGDA (Directorate General of Drug Administration)

linde bangladesh limited - liquid medical oxygen - gas - 99.5 %

Bangladesh - inglese - DGDA (Directorate General of Drug Administration)

rahman chemicals ltd. - liquid glucose - raw materials - 100%

Australia - inglese - APVMA (Australian Pesticides and Veterinary Medicines Authority)

valent biosciences a div of sumitomo chemical australia - gibberellic acid; gibberellic acid - liquid - gibberellic acid plant growth regulator active 100.0 g/l; gibberellic acid plant growth regulator active 64.0 g/l - plant regulator

Australia - inglese - Department of Health (Therapeutic Goods Administration)

seqirus pty ltd - vibrio cholerae, quantity: 31.25 billion organisms; vibrio cholerae, quantity: 1 mg - oral liquid, suspension - excipient ingredients: sodium chloride; dibasic sodium phosphate dihydrate; water for injections; monobasic sodium phosphate dihydrate - cholera caused by serogroup 01 vibrio cholerae: active immunisation of adults and children from two years of age, who will be visiting areas epidemic or endemic for cholera and who are at high risk of infection.

Australia - inglese - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - prednisolone sodium phosphate, quantity: 6.72 mg/ml (equivalent: prednisolone, qty 5 mg/ml) - oral liquid, solution - excipient ingredients: propylene glycol; dibasic sodium phosphate dodecahydrate; monobasic sodium phosphate; disodium edetate; methyl hydroxybenzoate; propyl hydroxybenzoate; purified water - whenever corticosteroid therapy is indicated.

Australia - inglese - Department of Health (Therapeutic Goods Administration)

johnson & johnson pacific pty ltd - liquid paraffin, quantity: 322 ml/l - oral liquid - excipient ingredients: maltol; hypromellose; saccharin sodium; vanillin; sorbic acid; benzoic acid; ethanol; agar; carbomer 941; sodium hydroxide; sodium sulfite; purified water; flavour - relief of acute and temporary constipation.